02/28/23 7:30 AMNasdaq : SBFM, SBFMW covid-19low floatSunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentSunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the signing of an exclusive worldwide license agreementRHEA-AIvery positive
02/10/23 7:35 AMNasdaq : SBFM, SBFMW low floatSunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundSunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the signing of a research agreement with Sir MortimerRHEA-AIneutral
01/19/23 7:30 AMNasdaq : SBFM, SBFMW buybacklow floatSunshine Biopharma Announces Share Repurchase ProgramSunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced its board of directors has authorized a shareRHEA-AIneutral
12/20/22 8:00 AMNasdaq : SBFM, SBFMW low floatSunshine Biopharma’s Annual Letter to ShareholdersSunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today issued a letter to shareholders from Dr. Steve Slilaty, ChairmanRHEA-AIpositive
11/16/22 8:00 AMNasdaq : SBFM, SBFMW low floatSunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA ProjectSunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals today announced that it has entered into a collaboration agreementRHEA-AIvery positive
10/20/22 8:00 AMNasdaq : SBFM, SBFMW acquisitionlow floatSunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueSunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has completed the acquisition of all the outstanding shares of NoraRHEA-AIneutral
08/04/22 8:00 AMNasdaq : SBFM, SBFMW earningslow floatSunshine Biopharma Files Its Second Quarter Report With the SECSunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviralRHEA-AIneutral
07/28/22 8:10 AMNasdaq : SBFM, SBFMW low floatSunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of ArizonaSunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has agreed to provideRHEA-AIneutral
04/28/22 4:50 PMNasdaq : SBFM, SBFMW low floatSunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-MarketSunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today closed its previously announcedRHEA-AIneutral
04/28/22 9:20 AMNasdaq : SBFM low floatAegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc.RHEA-AIneutral
